Alnylam Pharmaceuticals (NASDAQ:ALNY), with a market capitalization of $35.4 billion, has emerged as a leading player in the RNA interference (RNAi) therapeutics space, with a particular focus on ...

Broadly, registries are of two types: hospital-based and centralised or national registries. A hospital-based cancer registry ...

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial ...

The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access ...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to ...

The health wearables segment is largely dominated by chatter about smart rings, smartwatches, and bands. However, the concept of smart textiles has been around for a while, with names like Google ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Research suggests physicians are undervaluing how artificial intelligence can improve medical care.

My patients have shared with me a newfound mistrust over the safety of all vaccines since the Covid vaccine mandates were ...

Healthcare costs in individual and group markets are projected to increase by 8% in 2025, underscoring the need for accurate ...